Citius Pharmaceuticals (CTXR) Receivables - Net (2025 - 2026)
Citius Pharmaceuticals' (CTXR) quarterly Receivables - Net came in at $1.1 million in Q1 2026, down 73.35% on a QoQ basis from $4.0 million in Q4 2025.
Citius Pharmaceuticals (CTXR) Receivables - Net (2025 - 2026) Analysis & Trends
Citius Pharmaceuticals (CTXR) has 2 years of Receivables - Net data on file, last reported at $1.1 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.22 Bn | 132.37 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.29 Bn | 78.30 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.17 Bn | 59.98 Bn | 1.37 Bn |
| 4 | Moderna | 61.38 Bn | 56.24 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.18 Bn | 37.09 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.99 Bn | 27.68 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.45 Bn | 10.05 Bn | 668.28 Mn |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Citius Pharmaceuticals | 15.81 Mn | 15.81 Mn | 1.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.08 Mn |
| Mar 31, 2026 | 1.08 Mn |
| Dec 31, 2025 | 4.05 Mn |
| Dec 31, 2025 | 4.05 Mn |